An international research team led by scientists at Georgetown University have demonstrated the power of artificial intelligence to predict which viruses could infect humans — like SARS-CoV-2, the virus that led to the COVID-19 pandemic — which animals host them, and where they could emerge.
Their ensemble of predictive models of likely reservoir hosts, published January 10 in Lancet Microbe (“Optimizing predictive models to prioritize viral discovery in zoonotic reservoirs”), was validated in an 18-month project to identify specific bat species likely to carry betacoronaviruses, the group that includes SARS-like viruses.
“If you want to find these viruses, you have to start by profiling their hosts — their ecology, their evolution, even the shape of their wings,” explains the study’s senior author, Colin Carlson, PhD, an assistant research professor in the Department of Microbiology & Immunology and a member of Georgetown’s Center for Global Health Science and Security at Georgetown University Medical Center. “Artificial intelligence lets us take data on bats and turn it into concrete predictions: where should we be looking for the next SARS?”
Despite global investments in disease surveillance, it remains difficult to identify and monitor wildlife reservoirs of viruses that could someday infect humans. Statistical models are increasingly being used to prioritize which wildlife species to sample in the field, but the predictions being generated from any one model can be highly uncertain. Scientists also rarely track the success or failure of their predictions after they make them, making it hard to learn and make better models in the future. Together, these limitations mean that there is high uncertainty in which models may be best suited to the task.
This new study suggests that the search for closely-related viruses could be non-trivial, with over 400 bat species around the world predicted to host betacoronaviruses, a large group of viruses that includes those responsible for SARS-CoV (the virus that caused the 2002-2004 outbreak of SARS) and SARS-CoV-2 (the virus that causes COVID-19). Although the origin of SARS-CoV-2 remains uncertain, the spillover of other viruses from bats is a growing problem due to factors like agricultural expansion and climate change.
Greg Albery, PhD, a postdoctoral fellow in Georgetown’s Biology Department, says COVID-19 provided the impetus to expedite their research. “This is a really rare opportunity,” explains Albery. “Outside of a pandemic, we’d never learn this much about these viruses in this small a timeframe. A decade of research has been collapsed into about a year of publications, and it means we can actually show that these tools work.”
In the first quarter of 2020, the researcher team trained eight different statistical models that predicted which kinds of animals could host betacoronaviruses. Over more than a year, the team then tracked discovery of 40 new bat hosts of betacoronaviruses to validate initial predictions and dynamically update their models. The researchers found that models harnessing data on bat ecology and evolution performed extremely well at predicting new hosts. In contrast, cutting-edge models from network science that used high-level mathematics – but less biological data – performed roughly as well or worse than expected at random.
“One of the most important things our study gives us is a data-driven shortlist of which bat species should be studied further,” says Daniel Becker, PhD, assistant professor of biology at the University of Oklahoma. “After identifying these likely hosts, the next step is then to invest in monitoring to understand where and when betacoronaviruses are likely to spill over.”
Carlson says that the team is now working with other scientists around the world to test bat samples for coronaviruses based on their predictions.
“If we spend less money, resources, and time looking for these viruses, we can put all of those resources into the things that actually save lives down the road. We can invest in building universal vaccines to target those viruses, or monitoring for spillover in people that live near bats,” says Carlson. “It’s a win-win for science and public health.”
More from: Georgetown University Medical Center | University of Idaho | Louisiana State University | University of California Berkeley | Colorado State University | Pacific Lutheran University | Icahn School of Medicine at Mount Sinai | University of Glasgow | Université de Montréal | University of Toronto | Ghent University | University College Dublin | Cary Institute of Ecosystem Studies | American Museum of Natural History
The Latest on: Cell-reprogramming therapy for heart failure
- Billionaires Bankroll Cell Rejuvenation Tech as the Latest Gambit to Slow Agingon January 21, 2022 at 5:00 am
Startups bet that carefully controlled cell reprogramming may lead to age reversal, but hurdles remain On January 19, co-founders Rick Klausner and Hans Bishop publicly launched an aging research ...
- GlaxoSmithKline's top scientist Hal Barron quits to help make billionaires live for everon January 20, 2022 at 11:45 am
Altos Labs was incorporated in the US and the UK last year and is studying the potential of cell reprogramming technology ... key medicines including asthma treatment Nucala and HIV drug Cabenuva.
- Rejuvenation by controlled reprogramming is the latest gambit in anti-agingon January 18, 2022 at 4:00 pm
So-called partial reprogramming ... of cell types. Indeed, the Yamanaka factors may be most valuable as a tool for studying basic biology of aging and rejuvenation rather than as therapy.
- NGM Bio Outlines 2022 Strategic Priorities Across Its Portfolio of Clinical-Stage Oncology, Retinal and Liver and Metabolic Programson January 12, 2022 at 2:33 am
About NGM Biopharmaceuticals, Inc. NGM Bio is focused on discovering and developing novel, life-changing medicines for people whose health and lives have been disrupted by disease ... treatment ...
- Vaccine-like mRNA injection can be used to make CAR T cells in the bodyon January 11, 2022 at 10:06 am
Heart failure is often ... antigen receptor (CAR) T cell technology, which, until now, has required the harvesting of a patient's T cells and their genetic reprogramming in the lab to recognize ...
- CAR T Cells Generated In Vivo Reverse Fibrosis, Restore Cardiac Function in Mice with Heart Failureon January 7, 2022 at 12:00 am
“Standard CAR T cell ... heart failure. However, the researchers noted in their new report, “One caveat of that work is the indefinite persistence of engineered T cells similar to CAR T cell ...
- Innovative approach brings cell-reprogramming therapy for heart failure closer to realityon January 6, 2022 at 11:55 am
"Years ago, Dr. Cooley said to me, regarding the next procedures needed to help people with heart failure, "Todd, you got to do something that is dramatic." For me, cell reprogramming is a 21st ...
- Vaccine-like mRNA injection can be used to make CAR T cells in the bodyon January 6, 2022 at 11:03 am
"Fibrosis underlies many serious disorders, including heart failure ... T cell technology, which, until now, has required the harvesting of a patient's T cells and their genetic reprogramming ...
- Innovative approach brings cell-reprograming therapy for heart failure closer to realityon January 6, 2022 at 11:03 am
Cell reprogramming is a main interest of ... Innovative approach brings cell-reprograming therapy for heart failure closer to reality. ScienceDaily. Retrieved January 19, 2022 from ...
- Innovative approach brings cell-reprograming therapy for heart failure closer to realityon January 6, 2022 at 9:56 am
Cell reprogramming is a main interest of the ... whose research focuses on finding innovative therapeutic approaches for heart failure. “Heart failure remains the leading cause of death from ...
via Bing News